Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate CBP-201 in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps

NCT04783389 is registered in ClinicalTrials.gov with Connect Biopharm LLC as lead sponsor.

NCT NCT04783389
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04783389 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate CBP-201 in Adult Patients With Chronic Rhinosinusitis With Nasal Polyps
Lead sponsor
Connect Biopharm LLC
Phase
Phase 2
Overall status
Terminated
Start date
June 16, 2021
Completion date
June 10, 2022
Enrollment
40 (actual)
Sites
68

Conditions

As the registry lists them; a condition with its own page is linked.

chronic rhinosinusitis with nasal polyps